• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

选择性易感性报告对哌拉西林他唑巴坦治疗 和 菌血症的使用影响最小。

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for and bacteremia.

机构信息

University of Texas Southwestern Medical Center, Dallas, Texas.

Parkland Health and Hospital System, Dallas, Texas.

出版信息

Infect Control Hosp Epidemiol. 2021 Oct;42(10):1272-1274. doi: 10.1017/ice.2020.1385. Epub 2021 Jan 11.

DOI:10.1017/ice.2020.1385
PMID:33423705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8506344/
Abstract

Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cultures with either Escherichia coli or Klebsiella spp.

摘要

选择性级联报告抗生素药敏结果不会显著影响对哌拉西林他唑巴坦（PT）的降级治疗、PT 使用时间、住院时间或大肠埃希菌或克雷伯菌属单一致病菌阳性血培养患者的急性肾损伤和艰难梭菌感染发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ebf/8506344/d3be4f8186df/S0899823X20013859_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ebf/8506344/d3be4f8186df/S0899823X20013859_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ebf/8506344/d3be4f8186df/S0899823X20013859_fig1.jpg

相似文献

1
Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for and bacteremia.选择性易感性报告对哌拉西林他唑巴坦治疗 和 菌血症的使用影响最小。
Infect Control Hosp Epidemiol. 2021 Oct;42(10):1272-1274. doi: 10.1017/ice.2020.1385. Epub 2021 Jan 11.
2
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.哌拉西林-他唑巴坦与美罗培南对产 ESBLs 的大肠埃希菌或肺炎克雷伯菌血流感染且对头孢曲松耐药患者 30 天死亡率的影响：一项随机临床试验。
JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163.
3
Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing in Patients with Hematologic Malignancy.碳青霉烯类药物与头孢吡肟或哌拉西林他唑巴坦治疗血液恶性肿瘤患者产超广谱β-内酰胺酶菌血症的经验性治疗。
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01813-18. Print 2019 Feb.
4
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.发热性中性粒细胞减少儿童中产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌血症
Microb Drug Resist. 2015 Apr;21(2):244-51. doi: 10.1089/mdr.2014.0092. Epub 2014 Nov 14.
5
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.美罗培南与哌拉西林-他唑巴坦用于头孢曲松不敏感大肠埃希菌和克雷伯菌属所致血流感染的确定性治疗（MERINO试验）：一项随机对照试验的研究方案
Trials. 2015 Jan 27;16:24. doi: 10.1186/s13063-014-0541-9.
6
Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.哌拉西林-他唑巴坦的 MIC 对产超广谱β-内酰胺酶大肠埃希菌菌血症患者结局的影响。
Antimicrob Agents Chemother. 2013 Jul;57(7):3402-4. doi: 10.1128/AAC.00135-13. Epub 2013 Apr 22.
7
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.针对具有超广谱β-内酰胺酶（ESBL）表型的全球大肠杆菌和克雷伯菌属菌株集合，头孢吡肟与哌拉西林/他唑巴坦的比较活性。
Diagn Microbiol Infect Dis. 2007 Mar;57(3):341-4. doi: 10.1016/j.diagmicrobio.2006.08.016. Epub 2006 Dec 1.
8
Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.对于产超广谱β-内酰胺酶菌血症患者，与哌拉西林-他唑巴坦相比，碳青霉烯类治疗与生存率提高相关。
Clin Infect Dis. 2015 May 1;60(9):1319-25. doi: 10.1093/cid/civ003. Epub 2015 Jan 13.
9
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.经验性使用哌拉西林-他唑巴坦与碳青霉烯类药物治疗产超广谱β-内酰胺酶肠杆菌科细菌所致菌血症的比较
PLoS One. 2016 Apr 22;11(4):e0153696. doi: 10.1371/journal.pone.0153696. eCollection 2016.
10
Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance.哌拉西林-他唑巴坦耐药/第三代头孢菌素敏感的大肠埃希菌和肺炎克雷伯菌分离株：耐药机制和体外-体内不相符。
Int J Antimicrob Agents. 2020 Mar;55(3):105885. doi: 10.1016/j.ijantimicag.2020.105885. Epub 2020 Jan 8.

引用本文的文献

1
Impact of Selective Reporting of Antibiotic Susceptibility Test Results on Antibiotic Use in Patients with Bloodstream Infection with .选择性报告抗生素敏感性试验结果对血流感染患者抗生素使用的影响 。 你提供的原文似乎不完整，句末“with.”后面缺少具体内容。
Biomed Hub. 2024 May 20;9(1):67-72. doi: 10.1159/000537770. eCollection 2024 Jan-Dec.
2
Short report: impact of selective reporting of antibiotic susceptibility testing on antibiotic use in patients with bloodstream infection with Enterococcus faecalis.短篇报告：选择性报告抗生素药敏试验对屎肠球菌血流感染患者抗生素使用的影响。
Infection. 2023 Oct;51(5):1557-1562. doi: 10.1007/s15010-023-02045-4. Epub 2023 May 23.

本文引用的文献

1
Limited impact of selective susceptibility reporting of and isolates from concurrent blood and urine cultures.同时进行血培养和尿培养中分离出的[具体细菌名称1]和[具体细菌名称2]菌株的选择性药敏报告影响有限。 （你原文中“and”前后应该有具体细菌名称未给出，这里是补充完整后的翻译示意）
Infect Control Hosp Epidemiol. 2021 May;42(5):647-648. doi: 10.1017/ice.2020.308. Epub 2020 Jul 14.
2
Out of Sight-Out of Mind: Impact of Cascade Reporting on Antimicrobial Usage.眼不见，心不烦：级联报告对抗菌药物使用的影响
Open Forum Infect Dis. 2020 Jan 8;7(2):ofaa002. doi: 10.1093/ofid/ofaa002. eCollection 2020 Feb.
3
Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool.
选择性报告抗生素药敏试验结果：一种有前途的抗生素管理工具。
Expert Rev Anti Infect Ther. 2020 Mar;18(3):251-262. doi: 10.1080/14787210.2020.1715795. Epub 2020 Jan 29.
4
The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review.急性肾损伤的RIFLE和AKIN分类：一项批判性和全面性综述。
Clin Kidney J. 2013 Feb;6(1):8-14. doi: 10.1093/ckj/sfs160. Epub 2012 Jan 1.
5
Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting.微生物实验室中的抗菌药物管理：在医院环境中，选择性药敏报告对环丙沙星使用及革兰氏阴性菌分离株对环丙沙星敏感性的影响。
J Clin Microbiol. 2016 Sep;54(9):2343-7. doi: 10.1128/JCM.00950-16. Epub 2016 Jul 6.
6
Impact of microbiology cascade reporting on antibiotic de-escalation in cefazolin-susceptible Gram-negative bacteremia.微生物学级联报告对头孢唑林敏感革兰氏阴性菌血症中抗生素降阶梯治疗的影响
Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1151-7. doi: 10.1007/s10096-016-2645-5. Epub 2016 Apr 29.
7
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.实施抗生素管理计划：美国传染病学会和美国医疗保健流行病学学会指南
Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.
8
Impact of a Multimodal Antimicrobial Stewardship Program on Pseudomonas aeruginosa Susceptibility and Antimicrobial Use in the Intensive Care Unit Setting.多模式抗菌药物管理计划对重症监护病房环境中铜绿假单胞菌敏感性和抗菌药物使用的影响。
Crit Care Res Pract. 2011;2011:416426. doi: 10.1155/2011/416426. Epub 2011 May 19.
9
Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.由抗生素耐药革兰氏阴性菌引起的医源性感染的归因医院成本和住院时间。
Antimicrob Agents Chemother. 2010 Jan;54(1):109-15. doi: 10.1128/AAC.01041-09. Epub 2009 Oct 19.